Interventional Management for Cancer Pain

Cancer pain is a distressing result of disease, both primary and metastatic, as well as complications caused by cancer treatment. Medication management often is insufficient to adequately treat the ensuing pain or the complications of medical management limit acceptable dosage for pain control. In t...

Full description

Saved in:
Bibliographic Details
Published in:Current pain and headache reports 2011-08, Vol.15 (4), p.237-243
Main Authors: Cope, Doris K., Zhao, Zirong
Format: Article
Language:English
Subjects:
Analgesics, Opioid - administration & dosage
Analgesics, Opioid - adverse effects
Analgesics, Opioid - therapeutic use
Anti-Inflammatory Agents - therapeutic use
Cancer
Catheter Ablation
Electric stimulation therapy
Humans
Injections, Spinal
Internal Medicine
Local anesthesia
Medicine
Medicine & Public Health
Neoplasms - complications
Nerve Block
Pain
Pain - etiology
Pain - surgery
Pain Management
Pain Measurement
Pain Medicine
Sympatholytics - therapeutic use
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cancer pain is a distressing result of disease, both primary and metastatic, as well as complications caused by cancer treatment. Medication management often is insufficient to adequately treat the ensuing pain or the complications of medical management limit acceptable dosage for pain control. In these instances, interventional modalities are an additional tool in the pain physician’s armamentarium. Most commonly employed are intrathecal opioids, local anesthetic and clonidine infusions, neurolytic-nerve and sympathetic-ganglion blockade, and radiofrequency techniques. These are discussed in this article concomitantly with current outcome data as reported in the medical literature.
ISSN:1531-3433
1534-3081
DOI:10.1007/s11916-011-0206-2